Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Capital Expenditures: 2018-2024

Historic Capital Expenditures for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to $867,000.

  • ADC Therapeutics' Capital Expenditures was N/A to $327,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $867,000 for FY2024, which is 73.04% down from last year.
  • Latest data reveals that ADC Therapeutics reported Capital Expenditures of $867,000 as of FY2024, which was down 73.04% from $3.2 million recorded in FY2023.
  • In the past 5 years, ADC Therapeutics' Capital Expenditures ranged from a high of $3.4 million in FY2021 and a low of $687,000 during FY2022.
  • In the last 3 years, ADC Therapeutics' Capital Expenditures had a median value of $867,000 in 2024 and averaged $1.6 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first slumped by 79.97% in 2022, then spiked by 368.12% in 2023.
  • Yearly analysis of 5 years shows ADC Therapeutics' Capital Expenditures stood at $801,000 in 2020, then skyrocketed by 328.21% to $3.4 million in 2021, then crashed by 79.97% to $687,000 in 2022, then skyrocketed by 368.12% to $3.2 million in 2023, then crashed by 73.04% to $867,000 in 2024.